Geneos Wealth Management’s Morgan Stanley Pathway Large Cap Equity ETF MSLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.9K Buy
+1,089
New +$62.3K ﹤0.01% 1378
2025
Q2
– Sell
-158
Closed -$7.31K – 3241
2025
Q1
$7.31K Buy
+158
New +$7.65K ﹤0.01% 2389

Other funds holding MSLC

Geneos Wealth Management's MSLC Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in Morgan Stanley Pathway Large Cap Equity ETF (MSLC) in Q2 2026: 1,089 shares worth $63.9K. The stake represents ﹤0.01% of the portfolio and ranks #1378 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in MSLC as recently as Q1 2025.

Geneos Wealth Management first reported a position in MSLC in Q1 2025 and has held it in 2 quarters since. 33 funds tracked by Wall St. Rank hold MSLC as of Q2 2026.

  • Geneos Wealth Management held 1,089 shares of Morgan Stanley Pathway Large Cap Equity ETF worth $63.9K as of Q2 2026.
  • Morgan Stanley Pathway Large Cap Equity ETF was a new Geneos Wealth Management position in Q2 2026.
  • Morgan Stanley Pathway Large Cap Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1378 holding.
  • Geneos Wealth Management first reported a position in Morgan Stanley Pathway Large Cap Equity ETF in Q1 2025 and has held it in 2 quarters since.
  • 33 funds tracked by Wall St. Rank held Morgan Stanley Pathway Large Cap Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.